Ming Quan

1.1k total citations
37 papers, 799 citations indexed

About

Ming Quan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ming Quan has authored 37 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Ming Quan's work include Pancreatic and Hepatic Oncology Research (7 papers), Cancer-related gene regulation (6 papers) and Kruppel-like factors research (5 papers). Ming Quan is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Cancer-related gene regulation (6 papers) and Kruppel-like factors research (5 papers). Ming Quan collaborates with scholars based in China and United States. Ming Quan's co-authors include Jiujie Cui, Keping Xie, Yong Gao, Jingde Chen, Dacheng Xie, Shijun Yu, Min Shi, Zhiqin Chen, Jingde Chen and Li Li and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Ming Quan

34 papers receiving 792 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming Quan China 18 584 264 200 101 79 37 799
Yangfan Lv China 16 583 1.0× 359 1.4× 205 1.0× 130 1.3× 87 1.1× 31 892
Linquan Wu China 15 460 0.8× 311 1.2× 167 0.8× 144 1.4× 76 1.0× 34 714
Alice Faversani Italy 15 644 1.1× 419 1.6× 262 1.3× 113 1.1× 72 0.9× 20 1.0k
Yeonjoo Jung South Korea 18 689 1.2× 182 0.7× 241 1.2× 156 1.5× 56 0.7× 26 953
Chun Sun China 17 578 1.0× 238 0.9× 234 1.2× 86 0.9× 64 0.8× 26 847
Honggang Yu China 16 400 0.7× 225 0.9× 152 0.8× 72 0.7× 47 0.6× 22 605
Wensheng Qiu China 17 518 0.9× 271 1.0× 215 1.1× 162 1.6× 83 1.1× 71 842
Chengli Du China 17 719 1.2× 509 1.9× 236 1.2× 143 1.4× 73 0.9× 32 1.0k
Sui-Sui Dong China 10 650 1.1× 366 1.4× 250 1.3× 71 0.7× 67 0.8× 10 936

Countries citing papers authored by Ming Quan

Since Specialization
Citations

This map shows the geographic impact of Ming Quan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Quan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Quan more than expected).

Fields of papers citing papers by Ming Quan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Quan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Quan. The network helps show where Ming Quan may publish in the future.

Co-authorship network of co-authors of Ming Quan

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Quan. A scholar is included among the top collaborators of Ming Quan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Quan. Ming Quan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Zhiqin, et al.. (2024). An emerging aspect of cancer neuroscience: A literature review on chemotherapy-induced peripheral neuropathy. Cancer Letters. 611. 217433–217433. 4 indexed citations
3.
Ge, Weiyu, Y Wang, Ming Quan, et al.. (2024). Activation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib. Molecular Cancer. 23(1). 48–48. 23 indexed citations
4.
Quan, Ming, et al.. (2023). Novel KDM2B/SAV1 Signaling Pathway Promotes the Progression of Gastric Cancer. Genetics Research. 2023. 1–11. 2 indexed citations
5.
6.
Li, Shumin, Yue Ming, Haiyan Xu, et al.. (2023). Chemotherapeutic drugs-induced pyroptosis mediated by gasdermin E promotes the progression and chemoresistance of pancreatic cancer. Cancer Letters. 564. 216206–216206. 43 indexed citations
7.
Chong, Xiaodan, Jingde Chen, Nanxin Zheng, et al.. (2022). PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN. Molecular Cancer. 21(1). 118–118. 28 indexed citations
8.
Yu, Shijun, et al.. (2022). miR-15a and miR-20b sensitize hepatocellular carcinoma cells to sorafenib through repressing CDC37L1 and consequent PPIA downregulation. Cell Death Discovery. 8(1). 297–297. 14 indexed citations
9.
10.
Quan, Ming, Jiao Feng, Xiuying Xiao, et al.. (2020). Lysine demethylase 2 (KDM2B) regulates hippo pathway via MOB1 to promote pancreatic ductal adenocarcinoma (PDAC) progression. Journal of Experimental & Clinical Cancer Research. 39(1). 13–13. 19 indexed citations
11.
Chen, Jingde, Ming Quan, Zhiqin Chen, et al.. (2020). Camrelizumab in advanced or metastatic solid tumour patients with DNA mismatch repair deficient or microsatellite instability high: an open-label prospective pivotal trial. Journal of Cancer Research and Clinical Oncology. 146(10). 2651–2657. 11 indexed citations
12.
Li, Yandong, Shijun Yu, Xiao Wang, et al.. (2019). SRPK1 facilitates tumor cell growth via modulating the small nucleolar RNA expression in gastric cancer. Journal of Cellular Physiology. 234(8). 13582–13591. 19 indexed citations
13.
Sun, Jian, et al.. (2019). Fenofibrate potentiates chemosensitivity to human breast cancer cells by modulating apoptosis via AKT/NF-κB pathway. SHILAP Revista de lepidopterología. 1 indexed citations
14.
Chen, Jingde, Lin Chen, Jing Wu, et al.. (2019). High sensitive detection of circulating tumor cell by multimarker lipid magnetic nanoparticles and clinical verifications. Journal of Nanobiotechnology. 17(1). 116–116. 24 indexed citations
15.
Cui, Jiujie, Ming Quan, Dacheng Xie, et al.. (2019). A novel KDM5A/MPC-1 signaling pathway promotes pancreatic cancer progression via redirecting mitochondrial pyruvate metabolism. Oncogene. 39(5). 1140–1151. 45 indexed citations
16.
Guo, Kun, Jiujie Cui, Ming Quan, et al.. (2016). The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer. Clinical Cancer Research. 23(3). 687–696. 67 indexed citations
17.
Cui, Jiujie, Tao Xia, Yuanmei Gao, et al.. (2016). HGF/Met and FOXM1 form a positive feedback loop and render pancreatic cancer cells resistance to Met inhibition and aggressive phenotypes. Oncogene. 35(36). 4708–4718. 35 indexed citations
18.
Quan, Ming, Jiujie Cui, Tian Xia, et al.. (2015). Merlin/NF2 Suppresses Pancreatic Tumor Growth and Metastasis by Attenuating the FOXM1-Mediated Wnt/β-Catenin Signaling. Cancer Research. 75(22). 4778–4789. 44 indexed citations
19.
Cui, Jiujie, Min Shi, Ming Quan, & Keping Xie. (2013). Regulation of EMT by KLF4 in Gastrointestinal Cancer. Current Cancer Drug Targets. 13(9). 986–995. 56 indexed citations
20.
Quan, Ming, Peipei Wang, Jiujie Cui, Yong Gao, & Keping Xie. (2013). The roles of FOXM1 in pancreatic stem cells and carcinogenesis. Molecular Cancer. 12(1). 159–159. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yangfan Lv Breakdown of academic impact, for papers by Linquan Wu Breakdown of academic impact, for papers by Alice Faversani Breakdown of academic impact, for papers by Yeonjoo Jung Breakdown of academic impact, for papers by Chun Sun Breakdown of academic impact, for papers by Honggang Yu Breakdown of academic impact, for papers by Wensheng Qiu Breakdown of academic impact, for papers by Chengli Du Breakdown of academic impact, for papers by Sui-Sui Dong
Rankless by CCL
2026